Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb;32(2):196-197.
doi: 10.1016/j.jvir.2020.09.027. Epub 2020 Oct 23.

IO + IO = More to Know:: The Uncertain Potential for Combined Interventional and Immuno-Oncology

Affiliations
Comment

IO + IO = More to Know:: The Uncertain Potential for Combined Interventional and Immuno-Oncology

Daniel B Brown et al. J Vasc Interv Radiol. 2021 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ochoa de Olza M, Navarro Rodrigo B, Zimmermann S, Coukos G. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. Lancet Oncol 2020;21:3419–430. - PubMed
    1. Zhan C, Ruohoniemi D, Shanbhogue KP, Wei J, Welling TH, Gu P, et al. Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 2020;31:25–34. - PubMed
    1. Zheng J, Irani Z, Lawrence D, Flaherty K, Arellano RS. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series. J Vasc Interv Radiol 2019;29:1369–1375. - PubMed
    1. Levey AO, Elsayed M, Lawson DH, et al. Predictors of overall and progression-free survival in patients with ocular melanoma metasttic to the liver undergoing Y90 radioembolization. Cardiovasc Intervent Radiol 2020;43:254–263. - PubMed
    1. Ruohoniemi DM, Zhan C, Wei J, et al. Safety and effectiveness of Yttrium-90 radioembolization around the time of immune checkpoint inhibiotrs for unresectable hepatic metastases. J Vasc Interv Radiol 2020;31:1233–1241. - PubMed